Trademark: 98098323
Word
ABELZETA
Status
Pending
Status Code
681
Status Date
Wednesday, April 3, 2024
Serial Number
98098323
Mark Type
4000
Filing Date
Monday, July 24, 2023

Trademark Owner History
ABELZETA INC. - 1st New Owner Before Publication
CELLULAR BIOMEDICINE GROUP, INC. - Original Applicant

Classifications
41 Educational services, namely, the presentation of lectures and panel discussions in the field of medicine
40 Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy; custom manufacture of pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer and autoimmune diseases; custom manufacture of viral vectors and plasmids for research and clinical use; custom manufacture of excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use
5 Pharmaceutical and biological preparations for medical use, namely, for the treatment and prevention of diseases, namely, cancer and autoimmune diseases; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy; pharmaceutical and biological preparations for medical diagnostic use; diagnostic kits consisting primarily of cells for medical or clinical use; viral vectors and plasmids for clinical use; cells for medical use
1 Excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use; viral vectors and plasmids for scientific research
44 Cell therapy services, namely, immune cell therapy services and medical treatment using cultured cells; Collection and preservation of biological tissue, blood and cells; providing medical information; providing health information in the field of oncology; providing medical information in the field of pharmaceuticals and cell therapy; medical treatment services, namely, medical treatment of cancer, autoimmune, and inflammatory diseases; medical diagnostic services

Trademark Events
Mar 29, 2024
Approved For Pub - Principal Register
Mar 29, 2024
Examiner's Amendment Entered
Mar 29, 2024
Notification Of Examiners Amendment E-Mailed
Mar 29, 2024
Examiners Amendment E-Mailed
Mar 29, 2024
Examiners Amendment -Written
Mar 26, 2024
Assigned To Examiner
Dec 27, 2023
Automatic Update Of Assignment Of Ownership
Aug 22, 2023
New Application Office Supplied Data Entered
Jul 27, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24